| 000 | 01157 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518082253.0 | ||
| 264 | 0 | _c20201204 | |
| 008 | 202012s 0 0 eng d | ||
| 022 | _a2542-5641 | ||
| 024 | 7 |
_a10.1097/CM9.0000000000000638 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Xian | |
| 245 | 0 | 0 |
_aAdvances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia. _h[electronic resource] |
| 260 |
_bChinese medical journal _cFeb 2020 |
||
| 300 |
_a474-482 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntigens, CD19 _ximmunology |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy, Adoptive _xadverse effects |
| 650 | 0 | 4 |
_aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma _xtherapy |
| 650 | 0 | 4 |
_aReceptors, Chimeric Antigen _ximmunology |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aLi, Jing-Jing | |
| 700 | 1 | _aLu, Pei-Hua | |
| 773 | 0 |
_tChinese medical journal _gvol. 133 _gno. 4 _gp. 474-482 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CM9.0000000000000638 _zAvailable from publisher's website |
| 999 |
_c30556635 _d30556635 |
||